AR and posterior cortical atrophy: Compared to benign prostatic hyperplasia, AR expression is upregulated in primary PCa, and its expression continues to increase as the disease progresses to castration-resistant prostate cancer (CRPC) during androgen deprivation therapy (ADT) 3.